Smith Group Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-80
| Closed | -$4K | – | 279 |
|
|
2021
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 348 |
|
|
2021
Q3 | $3K | Hold |
80
| – | – | ﹤0.01% | 361 |
|
|
2021
Q2 | $5K | Hold |
80
| – | – | ﹤0.01% | 341 |
|
|
2021
Q1 | $3K | Sell |
80
-2,500
| -97% | -$93.8K | ﹤0.01% | 315 |
|
|
2020
Q4 | $148K | Sell |
2,580
-10
| -0.4% | -$574 | 0.01% | 189 |
|
|
2020
Q3 | $78K | Buy |
+2,590
| New | +$78K | ﹤0.01% | 205 |
|